COVID, FDA and local vaccine
Digest more
18hon MSN
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.
A day after the FDA tightened the restrictions for winning vaccine approvals, Moderna Inc. is pulling its application for approval of its flu-Covid combination vaccine.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the U.S. Food and Drug Administration.
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.
1h
Econostrum (English) on MSNFDA Restricts COVID-19 Booster Shots for Under-65s in Major Policy ShiftThe US Food and Drug Administration (FDA) has announced a significant revision to its COVID-19 vaccination policy, restricting access to seasonal booster shots for healthy Americans under the age of 65.
Explore more